Digital health is transforming how healthcare is delivered, accessed, and financed – with telemedicine, AI diagnostics, remote patient monitoring, electronic health records, and digital therapeutics all creating significant market opportunities. GreyRadius helps healthtech companies validate new markets, navigate regulatory requirements, execute GTM plans, and raise capital – grounded in primary research with clinicians, patients, payers, and health system administrators.
Why now? Healthcare system digitalisation is accelerating across Southeast Asia, South Asia, and the Gulf – driven by post-pandemic investment, national digital health strategies, and the recognition that physical healthcare infrastructure alone cannot serve growing populations. The healthtech companies that establish hospital and payer relationships in 2024–2027 will hold multi-year contract value.
Digital health investment in Southeast Asia and South Asia exceeded $4B in 2023 – growing at 18% annually as governments launch national digital health programmes and private healthcare groups digitise operations.
AI diagnostics is achieving clinical validation for radiology, pathology, and dermatology – regulatory approvals in the US, EU, and several Asian markets are creating commercial deployment opportunities.
Hospital information systems are being replaced across Southeast Asia and South Asia – legacy on-premise HIS installations are being migrated to cloud-based platforms, creating a large replacement market.
Pharmacy tech is growing at 30%+ annually – digital pharmacy platforms that combine online ordering, teleconsultation, and home delivery are capturing significant market share from traditional pharmacy networks.
If you recognise your situation below, we can help.
Entering a new digital health market
You need regulatory framework mapping, clinician adoption research, payer dynamics, and an entry roadmap before committing development and sales resources.
Healthtech product-market fit assessment
You have a digital health product and need to assess whether clinicians, patients, or health systems in a new market will adopt it.
GTM for a healthtech platform
You have an EHR system, telehealth platform, or clinical decision support tool and need a go-to-market strategy covering hospital acquisition and clinician outreach.
Raising capital for a digital health venture
You are raising investment and need a pitch book grounded in clinical evidence, market demand data, and investor-ready financial projections.
Telemedicine market entry
You are evaluating the telemedicine opportunity in a new market and need regulatory assessment, consumer adoption research, and a market entry roadmap.
Healthcare competitive intelligence
You need to understand how competing digital health platforms are positioned, priced, and acquiring hospital or patient customers in your target market.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate demand for a new healthtech product, market, or geography. Covers clinician and administrator interviews, patient adoption surveys, regulatory mapping, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for digital health investments and platform launches. Covers patient demand modelling, reimbursement pathway, revenue model, and investor-ready financial projections.
Learn more →End-to-end market entry for digital health and telemedicine companies. Regulatory pathway, hospital partner identification, clinician ICP definition, and first-institution or first-patient acquisition.
Learn more →Embedded GTM team for healthtech platforms. Hospital outreach, clinician relationship development, pipeline management, and first-subscription or first-institution milestone tracking.
Learn more →Investor-ready pitch books for digital health ventures. Clinical demand-validated market sizing, financial model, and investor identification across healthtech-focused PE and VC.
Learn more →AI use-case prioritisation in healthcare – from clinical decision support and diagnostic automation to patient engagement and administrative workflow optimisation.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Healthcare · Market Entry
Healthcare · GTM Execution
Healthcare · Assessment
Commercial-stage. We work with healthtech companies that have a validated product and are entering new markets, scaling GTM, or raising growth capital.
Southeast Asia, South Asia, the Gulf, and Africa – markets where digital health adoption is accelerating fastest.
Typically 6–10 weeks for the full research, strategy, and execution planning phase.
Yes. Structured interviews with clinicians, hospital administrators, and payers are a core part of our healthtech market entry methodology.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Southeast Asia, South Asia, Gulf, Africa.
